153 related articles for article (PubMed ID: 38709450)
1. Influence of UGT2B7, UGT1A4 and ABCG2 Polymorphisms on the Pharmacokinetics and Therapeutic Efficacy of Lamotrigine in Patients with Epilepsy.
Yang J; Wang J; Ning L; Wu C; Liu Y; Xia J; Guan Y; Liu Q; Zheng J
Eur J Drug Metab Pharmacokinet; 2024 May; ():. PubMed ID: 38709450
[TBL] [Abstract][Full Text] [Related]
2. Bearing variant alleles at uridine glucuronosyltransferase polymorphisms UGT2B7 -161C > T (rs7668258) or UGT1A4*3 c.142 T > G (rs2011425) has no relevant consequences for lamotrigine troughs in adults with epilepsy.
Božina N; Sporiš IŠ; Domjanović IK; Ganoci L; Šimičević L; Lovrić M; Romić ZČ; Gadže ŽP; Trkulja V
Eur J Clin Pharmacol; 2023 Aug; 79(8):1117-1129. PubMed ID: 37340142
[TBL] [Abstract][Full Text] [Related]
3. Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children.
Liu L; Zhao L; Wang Q; Qiu F; Wu X; Ma Y
Eur J Clin Pharmacol; 2015 Nov; 71(11):1341-7. PubMed ID: 26303110
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer resistance protein polymorphism ABCG2 c.421C>A (rs2231142) moderates the effect of valproate on lamotrigine trough concentrations in adults with epilepsy.
Šušak Sporiš I; Božina N; Klarica Domjanović I; Sporiš D; Bašić S; Bašić I; Lovrić M; Ganoci L; Trkulja V
Fundam Clin Pharmacol; 2024 Apr; 38(2):351-368. PubMed ID: 37793994
[TBL] [Abstract][Full Text] [Related]
5. Interaction between ABCG2 421C>A polymorphism and valproate in their effects on steady-state disposition of lamotrigine in adults with epilepsy.
Klarica Domjanović I; Lovrić M; Trkulja V; Petelin-Gadže Ž; Ganoci L; Čajić I; Božina N
Br J Clin Pharmacol; 2018 Sep; 84(9):2106-2119. PubMed ID: 29791014
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of ABCG2, ABCB1 and HNF4α are associated with Lamotrigine trough concentrations in epilepsy patients.
Zhou Y; Wang X; Li H; Zhang J; Chen Z; Xie W; Zhang J; Li J; Zhou L; Huang M
Drug Metab Pharmacokinet; 2015 Aug; 30(4):282-7. PubMed ID: 26213157
[TBL] [Abstract][Full Text] [Related]
7. Effect of UGT1A4, UGT2B7, UGT2B15, UGT2B17 and ABC1B polymorphisms on lamotrigine metabolism in Danish patients.
Petrenaite V; Öhman I; Jantzen FPT; Ekström L
Epilepsy Res; 2022 May; 182():106897. PubMed ID: 35303539
[TBL] [Abstract][Full Text] [Related]
8. Redefining the age-specific therapeutic ranges of lamotrigine for patients with epilepsy: A step towards optimizing treatment and increasing cost-effectiveness.
Wang ML; Wang HX; Zhao MM; Ma YY; Zhao LM
Epilepsy Res; 2021 Oct; 176():106728. PubMed ID: 34339940
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling.
Xu S; Liu L; Chen Y; Liu M; Lu T; Wang H; Liu S; Zhao M; Zhao L
Eur J Clin Pharmacol; 2018 May; 74(5):583-591. PubMed ID: 29340733
[TBL] [Abstract][Full Text] [Related]
10. Association of UGT2B7 and UGT1A4 Polymorphisms with Serum Concentration of Antiepileptic Drugs in Children.
Du Z; Jiao Y; Shi L
Med Sci Monit; 2016 Oct; 22():4107-4113. PubMed ID: 27795544
[TBL] [Abstract][Full Text] [Related]
11. Influence of the UGT2B7 -161C>T polymorphism on the population pharmacokinetics of lamotrigine in Thai patients.
Singkham N; Towanabut S; Lertkachatarn S; Punyawudho B
Eur J Clin Pharmacol; 2013 Jun; 69(6):1285-91. PubMed ID: 23263737
[TBL] [Abstract][Full Text] [Related]
12. UGT polymorphisms and lamotrigine clearance during pregnancy.
Petrenaite V; Öhman I; Ekström L; Sæbye D; Hansen TF; Tomson T; Sabers A
Epilepsy Res; 2018 Feb; 140():199-208. PubMed ID: 29395496
[TBL] [Abstract][Full Text] [Related]
13. Specific OCT1 and ABCG2 polymorphisms are associated with Lamotrigine concentrations in Chinese patients with epilepsy.
Shen CH; Zhang YX; Lu RY; Jin B; Wang S; Liu ZR; Tang YL; Ding MP
Epilepsy Res; 2016 Nov; 127():186-190. PubMed ID: 27610747
[TBL] [Abstract][Full Text] [Related]
14. Correlation of the UGT1A4 gene polymorphism with serum concentration and therapeutic efficacy of lamotrigine in Han Chinese of Northern China.
Chang Y; Yang LY; Zhang MC; Liu SY
Eur J Clin Pharmacol; 2014 Aug; 70(8):941-6. PubMed ID: 24820767
[TBL] [Abstract][Full Text] [Related]
15. Effects of UGT1A4 genetic polymorphisms on serum lamotrigine concentrations in Chinese children with epilepsy.
Wang Q; Liang M; Dong Y; Yun W; Qiu F; Zhao L; Guo Y
Drug Metab Pharmacokinet; 2015 Jun; 30(3):209-13. PubMed ID: 25922177
[TBL] [Abstract][Full Text] [Related]
16. Influence of genetic variants and antiepileptic drug co-treatment on lamotrigine plasma concentration in Mexican Mestizo patients with epilepsy.
Ortega-Vázquez A; Fricke-Galindo I; Dorado P; Jung-Cook H; Martínez-Juárez IE; Monroy-Jaramillo N; Rojas-Tomé IS; Peñas-Lledó E; Llerena A; López-López M
Pharmacogenomics J; 2020 Dec; 20(6):845-856. PubMed ID: 32483200
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of the Influence of UGT Genetic Polymorphisms on Lamotrigine Concentration.
Kim SC; Kim MG
Basic Clin Pharmacol Toxicol; 2019 Feb; 124(2):163-169. PubMed ID: 30168665
[TBL] [Abstract][Full Text] [Related]
18. Effects of UGT2B7 Genetic Polymorphisms on Serum Concentrations of Valproic Acid in Chinese Children With Epilepsy Comedicated With Lamotrigine.
Wang Q; Zhao L; Liang M; Dong Y; Yun W; Qiu F; Meng H; Guo Y
Ther Drug Monit; 2016 Jun; 38(3):343-9. PubMed ID: 26717295
[TBL] [Abstract][Full Text] [Related]
19. Factors that influence the pharmacokinetics of lamotrigine in Japanese patients with epilepsy.
Inoue K; Yamamoto Y; Suzuki E; Takahashi T; Umemura A; Takahashi Y; Imai K; Inoue Y; Hirai K; Tsuji D; Itoh K
Eur J Clin Pharmacol; 2016 May; 72(5):555-62. PubMed ID: 26790665
[TBL] [Abstract][Full Text] [Related]
20. Relationship Between UGT1A4 and UGT2B7 Polymorphisms and the Steady-State Plasma Concentrations of Lamotrigine in Patients With Treatment-Resistant Depressive Disorder Receiving Lamotrigine as Augmentation Therapy.
Suzuki T; Mihara K; Nagai G; Kagawa S; Nakamura A; Nemoto K; Kondo T
Ther Drug Monit; 2019 Feb; 41(1):86-90. PubMed ID: 30489548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
